Cannara Biotech Inc. (LOVFF)

Other OTC - Other OTC Delayed Price. Currency in USD

Add to watchlist

0.0910

+0.0037

(+4.27%)

At close: 03:55PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	0.0873
Open	0.0877
Bid	N/A x N/A
Ask	N/A x N/A
Day's Range	0.0877 - 0.0910
52 Week Range	0.0800 - 0.1500
Volume	3,308
Avg. Volume	19,684

Market Cap	79.805M
Beta (5Y Monthly)	1.74
PE Ratio (TTM)	91.00
EPS (TTM)	0.0010
Earnings Date	Apr 27, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for LOVFF

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

CANNARA BIOTECH INC
Analyst Report: Curaleaf Holdings, Inc.Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 22 states, including the assets from the Cura Select and Grassroots acquisitions. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.
Rating
Fair Value
Economic Moat
19 days agoMorningstar

All

Simply Wall St.
Cannara Biotech Inc.'s (CVE:LOVE) Stock Has Shown A Decent Performance: Have Financials A Role To Play?
Cannara Biotech's (CVE:LOVE) stock up by 4.8% over the past month. As most would know, long-term fundamentals have a...
- Hillicon Valley — Yubo app involved in Texas investigation
  The Hill
- Is Wall Financial Corporation's (TSE:WFC) ROE Of 9.2% Concerning?
  Simply Wall St.
CNW Group
Cannara Biotech Inc. to Present at Canaccord Genuity's 6th Annual Cannabis Conference on May 11th and Retains Bristol Capital for Investor Relations Services
Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced the Company's Chief Financial Officer, Nicholas Sosiak, will be presenting at Canaccord Genuity's 6th Annual Cannabis Conference at 10:30am Eastern on May 11th, 2022. Mr. Sosiak will present the Company's corporate highlights and also p
PR Newswire
Cannara Biotech Inc. Reports Fiscal Second Quarter 2022 Financial Results
Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced its fiscal second quarter 2022 financial and operating results for the three and six-month periods ended February 28, 2022.